Pro Doc Zolmitriptan ODT recall in Canada: Out of specification impurity
In plain language
This recall involves Pro Doc Zolmitriptan ODT tablets sold in Canada. It's being recalled because of an out-of-specification impurity result during stability testing. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot numbers on your product.
- Return the product as instructed by the official notice.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Zolmitriptan ODT tablet
Lot: 615991, 619093
Why this matters
Out of specification impurity
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 615991, 619093
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Out of specification impurity
What should consumers do?
Stop using the product immediately. Check the lot numbers on your product. Return the product as instructed by the official notice.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Out of specification impurity
When was this product recalled?
This product was recalled on February 26, 2020.
Is the Pro Doc brand affected by this recall?
Yes, Pro Doc products are affected by this recall. This recall involves Pro Doc Zolmitriptan ODT tablets sold in Canada. It's being recalled because of an out-of-specification impurity result during stability testing. Stop using the product and follow the return steps in the official notice.